OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Cancer: Current Use and Future Prospects
Henry Dickerson, Ahmad I Diab, Othman Al Musaimi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10008-10008
Open Access | Times Cited: 7
Henry Dickerson, Ahmad I Diab, Othman Al Musaimi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10008-10008
Open Access | Times Cited: 7
Showing 7 citing articles:
Advances in pyrazolo[1,5-a]pyrimidines: synthesis and their role as protein kinase inhibitors in cancer treatment
Terungwa H. Iorkula, Osasere Jude-Kelly Osayawe, Daniel A. Odogwu, et al.
RSC Advances (2025) Vol. 15, Iss. 5, pp. 3756-3828
Open Access | Times Cited: 2
Terungwa H. Iorkula, Osasere Jude-Kelly Osayawe, Daniel A. Odogwu, et al.
RSC Advances (2025) Vol. 15, Iss. 5, pp. 3756-3828
Open Access | Times Cited: 2
High-Yield Synthesis of N4-(3-Chloro-4-fluorophenyl)-7-((4-methoxybenzyl)thio)quinazoline-4,6-diamine via N-(3-Chloro-4-fluorophenyl)-7-((4-methoxybenzyl)thio)-6-nitroquinazolin-4-amine
Susila Thapa, Jeanne L. Bolliger
Molbank (2025) Vol. 2025, Iss. 1, pp. M1958-M1958
Open Access
Susila Thapa, Jeanne L. Bolliger
Molbank (2025) Vol. 2025, Iss. 1, pp. M1958-M1958
Open Access
The multiple biological activities of hyperoside: from molecular mechanisms to therapeutic perspectives in neoplastic and non-neoplastic diseases
Weisong Zhang, Rui Wang, Rongqi Guo, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Weisong Zhang, Rui Wang, Rongqi Guo, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Targeting EGFR-Mcl-1 Axis by Piperlongumine as a Novel Strategy for Non-Small Cell Lung Cancer Therapy
Wen Liu, Zhibin Jiang, Ruirui Wang, et al.
The American Journal of Chinese Medicine (2025), pp. 1-23
Closed Access
Wen Liu, Zhibin Jiang, Ruirui Wang, et al.
The American Journal of Chinese Medicine (2025), pp. 1-23
Closed Access
Rational computational Design of new-Generation EGFR tyrosine kinase (EGFR-TK) inhibitors
Chandraprakash Gond, Nikhil Kumar, Akanksha Mishra, et al.
Results in Chemistry (2025), pp. 102239-102239
Open Access
Chandraprakash Gond, Nikhil Kumar, Akanksha Mishra, et al.
Results in Chemistry (2025), pp. 102239-102239
Open Access
Potentiation of EGFR mutant lung cancer treatment targeting replication stress
Reshma Bhowmick, John J. Turchi, Shadia I. Jalal
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Reshma Bhowmick, John J. Turchi, Shadia I. Jalal
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Exploring the Effect of Gomisin A on Non‐Small Cell Lung Cancer With Network Pharmacology, Molecular Docking, In Vitro and In Vivo Assays
Mei Liu, Kai Yang, Huibing Qiu
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 5
Closed Access
Mei Liu, Kai Yang, Huibing Qiu
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 5
Closed Access
Characterization of Serratia marcescens (OK482790)’ prodigiosin along with in vitro and in silico validation for its medicinal bioactivities
Marwa A. Hamada, Eslam Mohamed
BMC Microbiology (2024) Vol. 24, Iss. 1
Open Access
Marwa A. Hamada, Eslam Mohamed
BMC Microbiology (2024) Vol. 24, Iss. 1
Open Access
